First, we transfected ErbB2-overexpressing SKBR3 and BT-474 or epidermal growth factor receptor (EGFR)-overexpressing MDA-MB-468 BC cell lines with control or two independent ECD siRNAs and then examined the levels of ErbB2 and EGFR. Here, ERBB2 is linked to breast cancer.